Angus C. Russell
CIK 1534002 · last filed 2025-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$123.9K
Companies
7
Total Filings
66
Lifetime Open-Market Net
$844.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LCTX | Director | 87,500 | $1.27 | $111.1K | -$14.0K | 7 | 2025-07-02 |
| GPCR | Director | — | $42.93 | — | $0 | 2 | 2025-06-25 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 0 | $3.65 | $0 | $100.7K | 14 | 2025-02-06 |
| TXMD | Director | 5,792 | $2.20 | $12.7K | $422.7K | 15 | 2022-10-03 |
| Keenova Therapeutics plc (MNK) Delisted | Director | 0 | $0.34 | $0 | -$6.7K | 13 | 2020-11-16 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Director | 67,500 | — | — | $191.5K | 5 | 2018-07-03 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 5,114 | — | — | $150.0K | 3 | 2013-11-13 |
Recent Filings · Page 3 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-07-02 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2020-06-19 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2020-05-15 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −12,042 | -$35.6K | EDGAR |
| 2020-05-15 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2019-08-26 | TXMD | Buy (P) | +10,000 | $27.7K | EDGAR |
| 2019-08-15 | TXMD | Buy (P) | +35,000 | $98.9K | EDGAR |
| 2019-07-03 | — | Grant (A) | — | $0 | |
| 2019-06-24 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2019-05-17 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +14,995 | -$178.9K | EDGAR |
| 2019-05-10 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.